All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
Short telomeres have been associated with cell senescence and DNA damage and might drive an important pathogenic mechanism which determines prognosis in patients with MDS. Telomerase inhibitors, like imetelstat, target cancer cells with short telomere lengths and hyperactive telomerase, preventing their expansion.